Release Date: 13/11/14 12:17 Summary: Notice of Compulsory Acquisition Price Sensitive: Yes Download Document 508.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%